Response to imatinib in patient with corticosteroid-unresponsive idiopatic hypereosinophilic syndrome
I.. Yilmaza,
, L.. Kaynarb, N.. Tutarc, C.. Palab, O.. Canozd, H.. Buyukoglanc, I.. Gulmezc
Corresponding author
a Erciyes University School of Medicine, Department of Chest Diseases, Division of Immunology and Allergy, Kayseri, Turkey
b Erciyes University School of Medicine, Department of Internal Medicine, Division of Hematology, Turkey
c Erciyes University School of Medicine, Department of Chest Diseases, Turkey
d Erciyes University School of Medicine, Department of Pathology, Turkey
Read
2037
Timeswas read the article
847
Total PDF
1190
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 33 | 8 | 41 |
| 2025 5 | 75 | 35 | 110 |
| 2025 4 | 51 | 30 | 81 |
| 2025 3 | 54 | 29 | 83 |
| 2025 2 | 41 | 25 | 66 |
| 2025 1 | 26 | 38 | 64 |
| 2024 12 | 37 | 26 | 63 |
| 2024 11 | 43 | 33 | 76 |
| 2024 10 | 36 | 23 | 59 |
| 2024 9 | 45 | 31 | 76 |
| 2024 8 | 52 | 58 | 110 |
| 2024 7 | 33 | 26 | 59 |
| 2024 6 | 50 | 40 | 90 |
| 2024 5 | 35 | 22 | 57 |
| 2024 4 | 26 | 22 | 48 |
| 2024 3 | 26 | 17 | 43 |
| 2024 2 | 33 | 19 | 52 |
| 2024 1 | 28 | 30 | 58 |
| 2023 12 | 18 | 24 | 42 |
| 2023 11 | 32 | 33 | 65 |
| 2023 10 | 28 | 31 | 59 |
| 2023 9 | 31 | 31 | 62 |
| 2023 8 | 31 | 9 | 40 |
| 2023 7 | 15 | 18 | 33 |
| 2023 6 | 15 | 25 | 40 |
| 2023 5 | 20 | 20 | 40 |
| 2018 7 | 2 | 0 | 2 |
| 2018 4 | 2 | 0 | 2 |
| 2018 2 | 3 | 0 | 3 |
| 2018 1 | 2 | 0 | 2 |
| 2017 12 | 4 | 0 | 4 |
| 2017 11 | 4 | 0 | 4 |
| 2017 10 | 2 | 0 | 2 |
| 2017 9 | 3 | 0 | 3 |
| 2017 8 | 2 | 0 | 2 |
| 2017 7 | 2 | 0 | 2 |
| 2017 6 | 4 | 0 | 4 |
| 2017 5 | 2 | 0 | 2 |
| 2017 4 | 2 | 0 | 2 |
| 2017 3 | 4 | 0 | 4 |
| 2017 2 | 4 | 1 | 5 |
| 2017 1 | 3 | 0 | 3 |
| 2016 12 | 5 | 0 | 5 |
| 2016 11 | 3 | 1 | 4 |
| 2016 10 | 7 | 0 | 7 |
| 2016 9 | 8 | 3 | 11 |
| 2016 8 | 4 | 2 | 6 |
| 2016 7 | 3 | 4 | 7 |
| 2016 4 | 31 | 9 | 40 |
| 2016 3 | 64 | 42 | 106 |
| 2016 2 | 106 | 82 | 188 |
Show all
